+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Enzyme polymorphism of NAT2 and GSTM1 in 179 bladder cancer patients in an area of former coal, iron and steel industries



Enzyme polymorphism of NAT2 and GSTM1 in 179 bladder cancer patients in an area of former coal, iron and steel industries



Proceedings of the American Association for Cancer Research Annual Meeting 38(0): 353




(PDF emailed within 1 workday: $29.90)

Accession: 031265407

Download citation: RISBibTeXText


Related references

Urinary bladder cancer risk factors in an area of former coal, iron, and steel industries in Germany. Journal of Toxicology and Environmental Health. Part a 80(7-8): 430-438, 2017

Urothelial cancer of the bladder in an area of former coal, iron, and steel industries in Germany: a case-control study. International Journal of Occupational and Environmental Health 4(2): 79-84, 1999

N-Acetyltransferase 2 (NAT2) and Glutathione S-Transferase ยต (GSTM1) in Bladder-cancer Patients in a Highly Industrialized Area. International Journal of Occupational and Environmental Health 3(2): 105-110, 1997

GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis 32(2): 182-189, 2011

Occupational prostate cancer risk factors in an area of coal, iron, and steel industries in Germany. European Journal of Cancer 35(SUPPL 4): S348, Sept, 1999

Occupational risk factors for prostate cancer in an area of former coal, iron, and steel industries in Germany. Part 2: results from a study performed in the 1990s. Journal of Toxicology and Environmental Health. Part a 79(22-23): 1130-1135, 2017

Occupational risk factors for prostate cancer in an area of former coal, iron, and steel industries in Germany. Part 1: Results from a study performed in the 1980s. Journal of Toxicology and Environmental Health. Part a 79(22-23): 1125-1129, 2017

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366(9486): 649-659, 2005

NAT2 Slow Acetylation, GSTM1 Null Genotype, and Risk of Bladder Cancer: Results from the Spanish Bladder Cancer Study and Meta-Analyses. European Urology 49(2): 412-0, 2006

Gender-specific effects of NAT2 and GSTM1 in bladder cancer. Clinical Genetics 57(4): 270-277, 2000

Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk. International Journal of Cancer 120(10): 2208-2213, 2007

Genetic polymorphisms of GSTM1, GSTP1, NAT1 and NAT2 in smoking-associated bladder cancer. Proceedings of the American Association for Cancer Research Annual Meeting 40: 89, 1999

Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2. Journal of Toxicological Sciences 23 Suppl 2: 140-142, 1998

Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. Bmc Cancer 6: 239, 2006

GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study. Anticancer Research 29(5): 1709-1714, 2009